Key facts
- It has raised $4.0M; the latest was Seed Round ($4.0M) in Mar 2026.
- Notable investors include e2vc, Point Nine Capital, TIBAS Ventures, Reece Chowdhry.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Forithmus
- ·The full record, as it builds
Funding rounds
No funding rounds for Forithmus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Forithmus
Operator of an AI-powered 3D medical imaging platform intended to empower radiologists, researchers, and developers by providing foundation models. The company's platform offers 3D medical imaging foundation models and a modern radiology workstation that generates AI-powered draft reports to streamline clinical workflows, enabling customers to leverage sophisticated automated analysis and secure research hubs.
- Sector
- Healthcare
- HQ
- Zurich, Switzerland
- Founded
- 2026
- Website
- forithmus.com/
- Ownership
- Privately Held (backing)
Forithmus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Forithmus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Forithmus in its N-PORT filings yet. We sweep new filings monthly.